Alpha Genesis, Inc.

company

About

Alpha Genesis is a full=service primate research center that provides nonhuman primate products and bio-research services world-wide

  • 101 - 250

Details

Last Funding Type
Funding Round
Last Funding Money Raised
$4.60M
Industries
Biopharma,Biotechnology,Health Care,Medical,Pharmaceutical,Veterinary
Founded date
Dec 31, 2003
Number Of Employee
101 - 250
Operating Status
Active

Alpha Genesis Inc. is a primate research center that provides nonhuman primate products and bio-research services world-wide. With a client base that extends across North America, Europe, and Asia, we are dedicated to providing only the best and most cost-effective primate research and development support to the scientific community. Included among our products and services are nonhuman primates for biomedical research, contract research services, biological products, and short- and long- term quarantine and general boarding. The Alpha Genesis Primate Research Center (AGPRC) is the designated Contract Research Organization (CRO) of Alpha Genesis Incorporated (AGI). The AGPRC research team is dedicated to fighting diseases ranging from Alzheimer’s to Zika and seeks to substantially improve human and animal health worldwide. In partnership with government organizations, private foundations, and private industry, AGPRC scientists conduct studies seeking breakthrough discoveries of causes, preventions, treatments and cures. The highly regulated study of nonhuman primates (NHPs) is critically important to improving human health worldwide, as investigations using nonhuman primate models often precedes clinical trials in humans and cannot be replicated any other way.

The Alpha Genesis Primate Research Center (AGPRC) is the designated Contract Research Organization (CRO) of Alpha Genesis Incorporated (AGI). The AGPRC research team is dedicated to fighting diseases ranging from Alzheimer’s to Zika and seeks to substantially improve human and animal health worldwide. In partnership with government organizations, private foundations, and private industry, AGPRC conducts studies seeking breakthrough discoveries of causes, preventions, treatments and cures. The highly regulated study of nonhuman primates (NHPs) is critically important, as it often precedes clinical trials in humans and cannot be replicated any other way.

If you have questions or would like to place an order, please email AGI at [email protected] or call toll-free 866.789.MONK (6665).

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$10.35M
Alpha Genesis, Inc. has raised a total of $10.35M in funding over 2 rounds. Their latest funding was raised on Jun 12, 2020 from a Funding Round round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 12, 2020 Funding Round $4.60M 1 Detail
Jun 20, 2019 Corporate Round $2M 1 Detail
Dec 4, 2018 Funding Round $750K 1 Detail
Sep 30, 2017 Funding Round $3M 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Alpha Genesis, Inc. is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Funding Round